CCL18 and lung carcinoma: MPE-Mφ showed relatively higher expression levels of M1 (IL-1β, IL-6, and CXCL10), M2 (CCL18 and IL-10), and pan-macrophage markers (CSF1 and PTPRC) compared to MDMs from lung cancer patients or HCs.